Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408) |
---|
03/18/1999 | WO1999012912A1 Thiourea derivatives or non-toxic salts thereof for inhibitng ras-transformed cell growth |
03/18/1999 | WO1999012902A1 N-heterocyclic methylpropylamine derivatives, process for producing the same and germicides |
03/18/1999 | CA2247551A1 Novel imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
03/17/1999 | EP0902018A2 2-(Arylphenyl)amino-imidazoline derivatives |
03/17/1999 | EP0902017A1 Transesterification process |
03/17/1999 | EP0901472A1 Mercapto-imidazolyl derivatives and their use as microbicides |
03/17/1999 | EP0655058B1 Pyridinyl/quinolinyl-terminated alkylamino ethynyl alanine amino diol compounds for treatment of hypertension |
03/17/1999 | EP0626962B1 Substituted phenylheterocyclic herbicides |
03/16/1999 | US5883261 Esterification reaction in the presence of sodium methoxide |
03/16/1999 | US5883260 Process for producing 1-substituted-hydantoins |
03/16/1999 | US5883258 Process for preparing 3-chlorobenzisothiazoles |
03/16/1999 | US5883252 Aspartyl protease inhibitors |
03/16/1999 | US5883105 Inhibitors of farnesyl-protein transferase |
03/16/1999 | CA1340442C Stabilizer composition and stabilized aqueous systems |
03/11/1999 | WO1999011658A1 Meta-benzamidine derivatives as serin protease inhibitors |
03/11/1999 | WO1999011657A1 1-amino-7-isoquinoline derivatives as serine protease inhibitors |
03/11/1999 | WO1999011253A1 Il-8 receptor antagonists |
03/11/1999 | CA2302364A1 Il-8 receptor antagonists |
03/10/1999 | EP0900224A1 Propagylglycine derivatives, preparation and utilisation thereof as synthesis intermediates |
03/10/1999 | EP0900198A1 New vitamin d derivatives with carbo- or heterocyclic substituents at c-25, a process for their production, intermediate products and their use for producing medicaments |
03/10/1999 | EP0900197A1 Beta-thiopropionyl-aminoacid derivatives and their use as beta-lactamase inhibitors |
03/10/1999 | CN1210520A Naphthol derivatives and process for preparation thereof |
03/10/1999 | CN1210517A Hydroxamic acid derivatives for use with treatment of diseases related to connective tissue degradation |
03/10/1999 | CN1210149A Overcoming DAPA aminotransferase bottlenecks in biotin vitamers |
03/09/1999 | US5880284 Cyclic urea derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
03/09/1999 | US5880147 Amide derivatives having ACAT inhibitory activity, their preparation and their therapeutic and prohylactic use |
03/09/1999 | US5880140 Biheteroaryl inhibitors of farnesyl-protein transferase |
03/09/1999 | US5880136 Sulfonamide fibrinogen receptor antagonists |
03/09/1999 | US5880129 Methods of inhibiting invasion and metastasis of malignant solid tumors |
03/09/1999 | US5879412 Compositions and processes for dyeing keratin fibers with an oxidation base, a coupler, a cationic direct dye, and an oxidizing agent |
03/04/1999 | WO1999010525A1 A method of treating cancer |
03/04/1999 | WO1999010524A1 A method of treating cancer |
03/04/1999 | WO1999010523A1 A method of treating cancer |
03/04/1999 | WO1999010330A1 Heterocyclic ketones as npy y5 antagonists |
03/04/1999 | WO1999010329A1 Inhibitors of prenyl-protein transferase |
03/04/1999 | WO1999010316A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
03/04/1999 | WO1999010314A2 Method for producing long-chain glycine-n,n-diacetic acid derivatives |
03/04/1999 | WO1999010313A1 N-aroylphenylalanine derivatives |
03/04/1999 | WO1999010312A1 N-alkanoylphenylalanine derivatives |
03/04/1999 | CA2301880A1 A method of treating cancer |
03/04/1999 | CA2301877A1 A method of treating cancer |
03/04/1999 | CA2301857A1 A method of treating cancer |
03/04/1999 | CA2301821A1 Heterocyclic ketones as npy y5 antagonists |
03/04/1999 | CA2301559A1 3-amidinoaniline derivatives, activated blood coagulation factor x inhibitors, and intermediates for producing both |
03/04/1999 | CA2300121A1 N-alkanoylphenylalanine derivatives |
03/04/1999 | CA2245755A1 2-(arylphenyl)amino-imidazoline derivatives |
03/03/1999 | EP0898963A2 Congestive heart failure treatment |
03/03/1999 | EP0898562A1 Hydroxamic acid derivatives for use with the treatment of diseases related to connective tissue degradation |
03/03/1999 | EP0724570B1 Amidino derivatives useful as nitric oxide synthase inhibitors |
03/03/1999 | EP0626957B1 Styril derivatives and processes for their preparation |
03/03/1999 | EP0500952B1 Process for producing nitrogenous heterocycle |
03/03/1999 | CN1209818A Method of producing press-moulding materials with polyisocyanate binders and using latent, heat-activable catalyst |
03/03/1999 | CN1209808A Halogen pyrimidines and its use thereof as parasite abatement means |
03/03/1999 | CN1209803A Conformationally restricted aromatic inhibitors of microsomal triglyceride transfer protein and method therefor |
03/03/1999 | CN1042328C Substituted cyclohexane derivative and medicine containing same |
03/02/1999 | US5877334 Of protease inhibitor |
03/02/1999 | US5877326 Aqueous phase process for preparing N-substituted imidazoles |
03/02/1999 | US5877325 Quaternary ammonium compounds as bleach activators and their preparation |
03/02/1999 | US5877324 Anticholesterol agent |
03/02/1999 | US5877196 N- 4-(imidazolyl or pyrazolyl)phenyl(oxy, sulfinyl, sulfenyl or sulfonyl)alkyl!carboxamides, sulfonamides or phosphoramides having antiarrhythmic properties |
03/02/1999 | US5877190 Substituted biphenyl compounds |
03/02/1999 | US5876666 Release from nonaqueous hydrogen peroxide complex, medical instruments |
02/25/1999 | WO1999008699A1 Growth hormone secretagogues |
02/25/1999 | WO1999008697A1 Treatment of congestive heart failure with growth hormone secretagogues |
02/25/1999 | WO1999008678A1 Heterocyclic vinylethers against neurological disorders |
02/25/1999 | DE19736476A1 Glycine-N,N-diacetic acid derivative preparation in high yield |
02/25/1999 | CA2302467A1 Growth hormone secretagogues |
02/25/1999 | CA2300848A1 Treatment of congestive heart failure with growth hormone secretagogues |
02/24/1999 | EP0897912A1 Amidino derivatives useful as nitric oxide synthase inhibitors |
02/24/1999 | EP0897556A1 Silver-halide recording material with improved storage stability to produce negatives with ultrahard-gradation contrast |
02/24/1999 | EP0673375B1 Fused benzo compounds |
02/24/1999 | CN1209122A Preventives/remedies for complication of diabetes |
02/23/1999 | US5874588 Reacting a diketopyrrolopyrrole with formic acid or or an alkali metal formate or alkaline earth metal formate together with carbon monoxide in the presence of a catalyst |
02/23/1999 | US5874587 Imidazolium cations, processes for their preparation, and uses therefor |
02/23/1999 | US5874467 Phenylacetic acid derivatives and use as fungicides |
02/23/1999 | US5874452 Biheteroaryl inhibitors of farnesyl-protein transferase |
02/18/1999 | WO1999008299A1 Nonaqueous electrolyte for electrical storage devices |
02/18/1999 | WO1999007672A1 Derivatives of 2,5- and 3,5-disubstituted anilines, their preparation and use |
02/17/1999 | EP0896535A1 Use of substituted aryl imidazoles |
02/17/1999 | CN1208405A Retroviral protease inhibiting compounds |
02/16/1999 | US5872260 High purity 1,3-dialkyl-2-imidazolidinone and preparation process of same |
02/16/1999 | US5872136 Enzyme inhibitors |
02/16/1999 | US5872129 Nitrobenzyl mustard quaternary salts and their use as hypoxia-selective cytotoxic agents |
02/16/1999 | US5872117 Treating cerebrovascular dementia, senile dementia, alzheimer's dementia, sequelae of ischemic encephalopathy and cerebral apoplexy |
02/16/1999 | US5872115 Compounds for treatment of hypercholesterolemia, ischemic heart disease, cerebrovascular disease or atherosclerosis |
02/11/1999 | WO1999006377A1 Derivatives of 1-((3,3-dimethyl-3-silabutoxy)methyl)-2-(phenylsulfonyl)imidazole |
02/11/1999 | WO1999006376A1 Novel sulphonamide derived from substituted anilines useful as medicines |
02/11/1999 | WO1999006361A2 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
02/11/1999 | WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors |
02/11/1999 | WO1999006032A2 Oral pharmaceutical preparation comprising an antiulcer activity compound, and process for its production |
02/11/1999 | WO1998050325A3 Building blocks derived from 1,2-aminoalcohols |
02/11/1999 | WO1998040420A3 Catalyst compositions for the polymerization of olefins |
02/11/1999 | CA2298617A1 Acyclic metalloprotease inhibitors |
02/10/1999 | EP0895991A2 Halogenating agent |
02/10/1999 | CN1207734A Metalloproteinase inhibitors, pharmaceutical compositions contg. them and their pharmaceutical uses, and methods and intermediates useful for their preparation |
02/10/1999 | CN1207732A Process for preparation of phenylimidazolidine derivs. |
02/10/1999 | CN1207727A Substd. aryl or heteroarylamides having retinoid-like biological activity |
02/09/1999 | US5869683 Processes for producing 1-substituted-2-cyanoimidazole compounds |
02/09/1999 | US5869682 Inhibitors of farnesyl-protein transferase |
02/09/1999 | US5869515 1,3-dihydro-2H-imidazol-2-one compounds |